1. Wedelolactone inhibits ferroptosis and alleviates hyperoxia-induced acute lung injury via the Nrf2/HO-1 signaling pathway.
- Author
-
Li K, Wang XQ, Liao ZL, Liu JY, Feng BH, Ren YC, Dai NN, Yu K, Yu H, Chen HJ, Mei H, and Qin S
- Subjects
- Animals, Male, Cell Line, Mice, Heme Oxygenase-1 metabolism, Heme Oxygenase (Decyclizing) metabolism, Heme Oxygenase (Decyclizing) genetics, Lung drug effects, Lung pathology, Lung metabolism, Disease Models, Animal, Apoptosis drug effects, Membrane Proteins, NF-E2-Related Factor 2 metabolism, Ferroptosis drug effects, Acute Lung Injury metabolism, Acute Lung Injury prevention & control, Acute Lung Injury etiology, Acute Lung Injury pathology, Acute Lung Injury drug therapy, Hyperoxia complications, Hyperoxia metabolism, Signal Transduction drug effects, Mice, Inbred C57BL, Coumarins pharmacology, Mice, Knockout
- Abstract
Hyperoxia-induced acute lung injury (HALI) is a complication of oxygen therapy. Ferroptosis is a vital factor in HALI. This paper was anticipated to investigate the underlying mechanism of wedelolactone (WED) on ferroptosis in HALI. The current study used hyperoxia to injure two models, one HALI mouse model and one MLE-12 cell injury model. We found that WED treatment attenuated HALI by decreasing the lung injury score and lung wet/dry (W/D) weight ratio and alleviating pathomorphological changes. Then, the inflammatory reaction and apoptosis in HALI mice and hyperoxia-mediated MLE-12 cells were inhibited by WED treatment. Moreover, WED alleviated ferroptosis with less iron accumulation and reversed expression alterations of ferroptosis markers, including MDA, GSH, GPX4, SLC7A11, FTH1, and TFR1 in hyperoxia-induced MLE-12 cells in vitro and in vivo. Nrf2-KO mice and Nrf2 inhibitor (ML385) decreased WED's ability to protect against apoptosis, inflammatory response, and ferroptosis in hyperoxia-induced MLE-12 cells. Collectively, our data highlighted the alleviatory role of WED in HALI by activating the Nrf2/HO-1 pathway., (© The Author(s) 2024. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF